# A Prospective, Multi-center Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency

> **NCT02443246** · PHASE3 · COMPLETED · sponsor: **Kwang Dong Pharmaceutical co., ltd.** · enrollment: 84 (actual)

## Conditions studied

- Vitamin D Deficiency

## Interventions

- **DRUG:** Vitamin D3 B.O.N. Injection (cholecalciferol 200,000IU)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02443246
- **Lead sponsor:** Kwang Dong Pharmaceutical co., ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-08
- **Final completion:** 2015-12
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2016-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02443246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02443246, "A Prospective, Multi-center Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02443246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*